These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21093338)

  • 1. Role of CYP450 in pharmacokinetics and pharmacogenetics of antihypertensive drugs.
    Rodríguez Arcas MJ; García-Jiménez E; Martínez-Martínez F; Conesa-Zamora P
    Farm Hosp; 2011; 35(2):84-92. PubMed ID: 21093338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms associated with antiepileptic metabolism.
    Lopez-Garcia MA; Feria-Romero IA; Fernando-Serrano H; Escalante-Santiago D; Grijalva I; Orozco-Suarez S
    Front Biosci (Elite Ed); 2014 Jun; 6(2):377-86. PubMed ID: 24896213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of CYP450 testing in the clinical setting.
    Samer CF; Lorenzini KI; Rollason V; Daali Y; Desmeules JA
    Mol Diagn Ther; 2013 Jun; 17(3):165-84. PubMed ID: 23588782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacogenetics and antiepileptic drug metabolism: implication of genetic variants in cytochromes P450].
    Saldaña-Cruz AM; Sánchez-Corona J; Márquez de Santiago DA; García-Zapién AG; Flores-Martínez SE
    Rev Neurol; 2013 May; 56(9):471-9. PubMed ID: 23629749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacogenetics or "farm-ecogenetics"?].
    Gérard N; Elion J; Krishnamoorthy R
    J Soc Biol; 2000; 194(1):9-13. PubMed ID: 11107543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 in Cancer Susceptibility and Treatment.
    Mittal B; Tulsyan S; Kumar S; Mittal RD; Agarwal G
    Adv Clin Chem; 2015; 71():77-139. PubMed ID: 26411412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining screening panel of functional variants of CYP1A1, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 genes in Serbian population.
    Skadrić I; Stojković O
    Int J Legal Med; 2020 Mar; 134(2):433-439. PubMed ID: 31858263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population.
    Arvanitidis K; Ragia G; Iordanidou M; Kyriaki S; Xanthi A; Tavridou A; Manolopoulos VG
    Fundam Clin Pharmacol; 2007 Aug; 21(4):419-26. PubMed ID: 17635181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacogenetics and potential application in personalized medicine.
    Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
    Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of Cytochrome P450 Enzymes in American Indian and Caucasian Children Admitted to a Psychiatric Hospital.
    McGrane IR; Loveland JG
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):395-9. PubMed ID: 26871369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacogenetics and pharmacogenomics. Searching for individual antihypertensive therapy concepts].
    Brand E
    MMW Fortschr Med; 2003 May; 145(19):43-4. PubMed ID: 12813978
    [No Abstract]   [Full Text] [Related]  

  • 12. Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population.
    Aynacioglu AS; Sachse C; Bozkurt A; Kortunay S; Nacak M; Schröder T; Kayaalp SO; Roots I; Brockmöller J
    Clin Pharmacol Ther; 1999 Aug; 66(2):185-92. PubMed ID: 10460072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania.
    Staehli Hodel EM; Csajka C; Ariey F; Guidi M; Kabanywanyi AM; Duong S; Decosterd LA; Olliaro P; Beck HP; Genton B
    Antimicrob Agents Chemother; 2013 Feb; 57(2):950-8. PubMed ID: 23229480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.
    Gaikovitch EA; Cascorbi I; Mrozikiewicz PM; Brockmöller J; Frötschl R; Köpke K; Gerloff T; Chernov JN; Roots I
    Eur J Clin Pharmacol; 2003 Aug; 59(4):303-12. PubMed ID: 12879168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between 3,4‑dichlorophenyl‑propenoyl‑sec.‑butylamine (3,4‑DCPB), an antiepileptic drug, and cytochrome P450 in rat liver microsomes and recombinant human enzymes in vitro.
    Cheng HX; Lu YY; Wang X; Ren H; Li Q; Wang SM; Ding Y; Lou YQ; Zhang GL
    Eur J Pharm Sci; 2018 Oct; 123():241-248. PubMed ID: 30010032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study for the characterization of pharmacogenetically relevant CYP2D6, CYP2C19 and ABCB1 gene polymorphisms in the Hungarian population.
    Rideg O; Háber A; Botz L; Szücs F; Várnai R; Miseta A; Kovács GL
    Cell Biochem Funct; 2011 Oct; 29(7):562-8. PubMed ID: 21826689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 metabolic phenotypes and genotypes in a Nicaraguan Mestizo population.
    de Andrés F; Altamirano-Tinoco C; Ramírez-Roa R; Montes-Mondragón CF; Dorado P; Peñas-Lledó EM; LLerena A
    Pharmacogenomics J; 2021 Apr; 21(2):140-151. PubMed ID: 33024249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination analysis in genetic polymorphisms of drug-metabolizing enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese population.
    Ota T; Kamada Y; Hayashida M; Iwao-Koizumi K; Murata S; Kinoshita K
    Int J Med Sci; 2015; 12(1):78-82. PubMed ID: 25552922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
    Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E
    Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.